News Online Neurology Resource Platform Launches Recent MS Research Findings Online Neurology Resource Platform Launches Recent MS Research Findings by Patricia Silva, PhD | March 26, 2015 Share this article: Share article via email Copy article link The online community for neurologists Neurology TimesĀ will feature special coverage focused on multiple sclerosis (MS) in celebration ofĀ MS Awareness Month, which is currently taking place in March. The online platform was designed to provide healthcare professionals with informational resources about several hard to treat diseases and requires registration to access the data. In order to celebrate this month dedicated to MS, an inflammatory disease of the nervous system that affects 2.5 million people all over the world including overĀ 400,000 patients in the United States, the online platform is offering new resources about MS. The announcement was made by publishers UBM Medica US and aims to improve knowledge ofĀ the disease for which there is currently no cure or means of prevention. TheĀ resources will focus on the latest MS research findings and newest therapeutic options available for patients so that physicians can stayĀ up to date on the most recent treatments and studies. Among the features areĀ three new discoveries made about the relationship betweenĀ food consumptionĀ and the disease. [adrotate group=”4″] Studies recently conducted demonstrated that the drinkingĀ coffee may reduce the probability of developing MS. In addition, femaleĀ MS patients in a study wereĀ found to have consumed lower levels of antioxidant and anti-inflammatory nutrients. These new findings correlate withĀ the recent identification of the pathological progression of MS, which researchers believe will leadĀ to the development of novel therapies. Another editorial focus is on theĀ drugĀ Guanabenz, which was approved by the U.S. Food and Drug Administration (FDA) to treat high blood pressure and has been demonstrated effective in preventing the loss of myelin as well as reducing the symptoms associated withĀ MS. The results ofĀ studies conducted in mice may lead to promising research intoĀ new therapies for the disease. The coverage also presents research on the role of stem cells to treat severe MS, which revealed thatĀ intense immunosuppression as well asĀ autologous hematopoietic stem cell transplantation can improve the treatment of MS patients who suffer from aĀ lack of response to standard therapies. Finally, another study, which focused on the stratified PML risk in MS,Ā highlighted the challenges experienced by physicians regarding the management of the disease inĀ patients takingĀ TysabriĀ and who areĀ positive for JC virus antibodies. The editors at Neurology Times believe that these recent findings are among the most promising and headline-grabbing in the MS research field, and chose to further highlight them during MS Awareness Month so that physicians and patients alike can become better informed about the progress being made to fight the disease. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags MS Awareness Month, multiple sclerosis
April 25, 2024 News by Margarida Maia, PhD Having MS may marginally increase likelihood of cervical cancer: Study
April 25, 2024 News by Marisa Wexler, MS MS patients prefer Tysabri injection to intravenous infusion: Study
April 24, 2024 News by Andrea Lobo, PhD Foralumab found to ease fatigue in SPMS patients in access program